Stool samples collection. Peking University Shenzhen Hospital (PKUSZH), Shenzhen Children’s Hospital (SCH), and The Eighth Affiliated Hospital, Sun Yat-Sen University (SYSU8H) were selected as sentinel hospitals. Stool samples were collected from outpatients who visited gastroenteritis clinic due to acute infectious diarrhea and agreed to take part in this study. Acute diarrhea was defined as over3 passages of loose, mucus-, watery, or bloody-stools during 24-hour period. The stool samples were examined for Salmonella sp. using CHROM agars. The clinical signs and demographic information were collected from electronic medical records.
A total of 5,239 cases (2,749 of whom were male) were included during study period. Among these patients, 3,870, 425, and 944 cases were enrolled from PKUSZH, SCH, and SYSU8H, respectively. Patients ranged in age from 0 to 96 years (median 30 years). Local population accounted for 60.4% of the patients. Of all the patients, 310 (5.9%) had fever, 635 (12.1%) had vomiting, and 50 (1.0%) had blood in stools, respectively. Of the patients over 5 years old, 2,098 (54.1%) had abdominal pain (Table 1). Overall, Salmonella was isolated from 297 (5.7%) of all cases.
Serotyping and antimicrobial susceptibility testing. The Salmonella sp. isolates were identified using Vitek-2 compact system (bioMerieux, France) and serotyped with a commercial serotyping kit (S&A company, S&A Reagent Lab, Bangkok, Thailand).
A total of 197 Salmonella isolates representing 26 serotypes were selected for antimicrobial susceptibility testing. Twenty-four antimicrobials (Oxoid, UK) including amikacin (30 micrograms (mcg), AK), ampicillin/sulbactam (20 mcg, SAM), ampicillin (10 mcg, AMP), aztreonam (30 mcg, ATM), cefepime (30 mcg, FEP), cefotaxime (30 mcg, CTX), cefoxitin (30 mcg, FOX), ceftazidime (30 mcg, CAZ), ceftriaxone (30 mcg, CRO), cephazolin (30 mcg, KZ), chloramphenicol (30 mcg, C), ciprofloxacin (5 mcg, CIP), gentamicin (10 mcg, CN), imipenem (10 mcg, IPM), levofloxacin (5 mcg, LEV), meropenem (10 mcg, MEM), nalidixic acid (30 mcg, NA), nitrofurantoin (300 mcg, F), norfloxacin (10 mcg, NOR), piperacillin (100 mcg, PRL), streptomycin (10 mcg, S), sulphamethoxazole/trimethoprim (25 mcg, SXT), tetracycline (30 mcg, TE), and trimethoprim (5 mcg, W) were tested using disk diffusion method.
The MacFarland 0.5 inoculums were prepared and swabbed on the entire surface of Mueller-Hinton agar (Huankai, China) and left to dry for 3-5 min. Antimicrobial susceptibility test discs (Oxoid, UK) were placed on the inoculated agar plate with a disc dispenser (Oxoid, UK) and incubated at 37℃ for 24h. After incubation, the diameter of inhibition zone was measured and the results were interpreted as susceptible, intermediate, and resistant according to the Clinical and Laboratory Standards Institute guideline (CLSI, 2019)[20]. Escherichia coli strain ATCC 25922 was used as quality control.
The multiple antibiotic resistance (MAR) index was the ratio between the number of antibiotics to which the organism was resistant and the number of antibiotics tested. Multi-drug resistant (MDR) was defined as resistant to three or more different classes of antimicrobial agents.
Detection of target gene mutations. A total of 21 fluoroquinolone resistant isolates were chosen to screen for the mutations of the gyrA, gyrB, parC, and parE genes in the QRDRs. The bacterial nucleic acid was extracted using QIAamp DNA Mini Kit (Qiagen GmbH, Hilden, Germany) and subjected to PCR amplification using Taq PCR Master Mix Kit (Qiagen GmbH, Hilden, Germany), according to the manufacturer’s recommended protocols. The PCR products were sent to Sangon (Shanghai, China) for sequencing and the results were analyzed using BLAST (PubMed). The primers used for PCR amplification and sequencing were listed in Table 2.